Search All UT System Experts

Baseline serum prostate specific antigen (PSA) levels predict degree of symptom improvement following therapy of benign prostatic hyperplasia (BPH) with finasteride

Peter Bovle, A. Lawrence, Claus Roehrborn

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Baseline serum prostate specific antigen (PSA) levels predict degree of symptom improvement following therapy of benign prostatic hyperplasia (BPH) with finasteride'. Together they form a unique fingerprint.

Medicine & Life Sciences